Collin D. Heer

547 total citations
16 papers, 395 citations indexed

About

Collin D. Heer is a scholar working on Molecular Biology, Cancer Research and Nutrition and Dietetics. According to data from OpenAlex, Collin D. Heer has authored 16 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Nutrition and Dietetics. Recurrent topics in Collin D. Heer's work include Cancer, Hypoxia, and Metabolism (5 papers), Mitochondrial Function and Pathology (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Collin D. Heer is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Mitochondrial Function and Pathology (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (3 papers). Collin D. Heer collaborates with scholars based in United States, Japan and Germany. Collin D. Heer's co-authors include Charles Brenner, Douglas R. Spitz, Michael S. Cohen, Yousef M. Alhammad, Anthony R. Fehr, Samuel A.J. Trammell, Stanley Perlman, Mark S. Schmidt, Yueming Zhu and Nobuo Horikoshi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Collin D. Heer

13 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Collin D. Heer United States 8 161 72 58 52 42 16 395
Sneha Mishra India 9 206 1.3× 57 0.8× 54 0.9× 139 2.7× 27 0.6× 25 469
Joseph R. Inigo United States 10 360 2.2× 51 0.7× 9 0.2× 15 0.3× 44 1.0× 13 553
Garret Vincent United States 7 270 1.7× 68 0.9× 7 0.1× 16 0.3× 55 1.3× 9 419
Jessica Díaz‐Elizondo Chile 9 231 1.4× 22 0.3× 31 0.5× 14 0.3× 20 0.5× 11 404
Veronika Kulikova Russia 9 183 1.1× 167 2.3× 205 3.5× 233 4.5× 20 0.5× 13 461
Joohong Park Australia 8 125 0.8× 250 3.5× 16 0.3× 31 0.6× 53 1.3× 11 489
Markus A. Engelen Germany 18 454 2.8× 62 0.9× 16 0.3× 8 0.2× 15 0.4× 32 988
Shree Bose United States 8 229 1.4× 91 1.3× 8 0.1× 7 0.1× 52 1.2× 11 450
Jeong A Choi South Korea 10 183 1.1× 19 0.3× 41 0.7× 12 0.2× 18 0.4× 11 409
Afthab Hussain United Kingdom 10 163 1.0× 41 0.6× 45 0.8× 16 0.3× 22 0.5× 32 372

Countries citing papers authored by Collin D. Heer

Since Specialization
Citations

This map shows the geographic impact of Collin D. Heer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collin D. Heer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collin D. Heer more than expected).

Fields of papers citing papers by Collin D. Heer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Collin D. Heer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collin D. Heer. The network helps show where Collin D. Heer may publish in the future.

Co-authorship network of co-authors of Collin D. Heer

This figure shows the co-authorship network connecting the top 25 collaborators of Collin D. Heer. A scholar is included among the top collaborators of Collin D. Heer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Collin D. Heer. Collin D. Heer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Borcherding, Nicholas, Adam J. Rauckhorst, Wade R. Gutierrez, et al.. (2025). Somatic CRISPR tumorigenesis and multiomic analysis reveal a pentose phosphate pathway disruption vulnerability in MPNSTs. Science Advances. 11(33). eadu2906–eadu2906.
3.
Stein, Colleen S., et al.. (2025). Mitoregulin Promotes Cell Cycle Progression in Non-Small Cell Lung Cancer Cells. International Journal of Molecular Sciences. 26(5). 1939–1939.
4.
Sishc, Brock J., Lianghao Ding, Taek‐Keun Nam, et al.. (2021). Avasopasem manganese synergizes with hypofractionated radiation to ablate tumors through the generation of hydrogen peroxide. Science Translational Medicine. 13(593). 37 indexed citations
5.
Hattori, Tsuyoshi, Hiroshi Ishii, Mika Takarada‐Iemata, et al.. (2021). Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide‐induced microglial and astrocytic neuroinflammation by increasing NAD+. Journal of Neurochemistry. 158(2). 311–327. 65 indexed citations
6.
Heer, Collin D., Yousef M. Alhammad, Mark S. Schmidt, et al.. (2020). Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity. Journal of Biological Chemistry. 295(52). 17986–17996. 137 indexed citations
7.
Heer, Collin D. & Charles Brenner. (2020). Letting off electrons to cope with metabolic stress. Nature Metabolism. 2(6). 485–486. 2 indexed citations
8.
Cramer-Morales, Kimberly, Collin D. Heer, Kranti A. Mapuskar, & Frederick E. Domann. (2020). Succinate Accumulation Links Mitochondrial MnSOD Depletion to Aberrant Nuclear DNA Methylation and Altered Cell Fate. PubMed. 1(2). 60–70. 6 indexed citations
9.
Zhu, Yueming, et al.. (2018). Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy. Journal of Clinical Investigation. 128(9). 3682–3691. 67 indexed citations
10.
Heer, Collin D., Andrew Davis, Brett A. Wagner, et al.. (2018). Superoxide Dismutase Mimetic GC4419 Enhances the Oxidation of Pharmacological Ascorbate and Its Anticancer Effects in an H2O2-Dependent Manner. Antioxidants. 7(1). 18–18. 37 indexed citations
11.
12.
Story, Michael D., Brock J. Sishc, David A. Bloom, et al.. (2018). The Radioprotector GC4419 Ameliorates Radiation Induced Lung Fibrosis While Enhancing the Response of Non-Small Cell Lung Cancer Tumors to High Dose per Fraction Radiation Exposures. International Journal of Radiation Oncology*Biology*Physics. 102(3). S187–S187. 1 indexed citations
13.
Heer, Collin D., Andrew Davis, Brett A. Wagner, et al.. (2017). Penta-azamacrocyclic SOD Mimetics Enhance Pharmacological Ascorbate Oxidation and Anticancer effects in an H2O2-dependent Manner. Free Radical Biology and Medicine. 112. 90–91. 1 indexed citations
14.
O’Leary, Brianne R., et al.. (2017). Inhibition of Peroxide Removal Enhances Pharmacological Ascorbate and Ionizing Radiation-Induced Cytotoxicity of Pancreatic Ductal Adenocarcinoma. Free Radical Biology and Medicine. 112. 97–97. 2 indexed citations
15.
Cramer-Morales, Kimberly, Collin D. Heer, Kranti A. Mapuskar, & Frederick E. Domann. (2015). SOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD. Free Radical Biology and Medicine. 89. 379–386. 22 indexed citations
16.
Heer, Collin D., K. Stuertz, Ralf René Reinert, Michael Mäder, & Roland Nau. (2000). Release of Teichoic and Lipoteichoic Acids from 30 Different Strains of Streptococcus pneumoniae during Exposure to Ceftriaxone, Meropenem, Quinupristin/Dalfopristin, Rifampicin and Trovafloxacin. Infection. 28(1). 13–20. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026